Jeff Moore

LDL receptor and pathogen processes: Functions beyond normal lipids.

M. Budoff, Jairo Aldana-Bitar, J. Aldana-Bitar, 2021, Journal of clinical lipidology.

Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer

J. Marshall, R. Dickson, J. Low, 2004, Investigational New Drugs.

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

David Bebbington, E. Harrington, C. Demur, 2004, Nature Medicine.